同时看到导管内癌与浸润性导管癌。
Both intraductal and infiltrating ductal carcinoma are seen here.
此为他们起源于下方的导管癌的证据。
This is evidence for their origin from an underlying ductal carcinoma.
涎腺导管癌临床病理分析。
The Clinicopathological Analysis of Salivary Duct Carcinoma.
方法：本研究对6例涎腺导管癌进行临床病理分析。
Methods: This study was to investigate clinicopathological characteristic of 6 salivary duct carcinomas.
高倍视野下，浸润性导管癌多形性癌细胞侵入基质。
At high magnification, the infiltrating ductal carcinoma of breast has pleomorphic cells infiltrating through the stroma.
换言之，某些导管癌和小叶癌一样，有这个抗体的强表达。
In other words, some ductal carcinomas have strong expression of this marker just like lobular carcinomas do.
左边典型的浸润性导管癌与右边良性纤维腺瘤的肉眼特征的近距离比较。
Here is a side by side comparison of the gross characteristics of a classic infiltrating ductal carcinoma on the left and a benign fibroadenoma on the right.
浸润性导管癌发病率最高，占44.9%，其次为单纯癌，占34.3%。
Infiltrating duct cancer was a high incidence (44.9%) and the secondary was simple cancer (34.3%).
目的探讨头皮鳞样小汗腺导管癌的临床病理和免疫表型特征及诊断与鉴别诊断。
Purpose to explore the clinicopathologic characteristics, immunohistochemistry, diagnosis and differential diagnosis of squamoid eccrine ductal carcinoma of the scalp.
在导管原位癌和浸润癌的病例中均可看到某些导管癌模仿小叶癌的组织学特点。
Histology of some ductal carcinomas mimics lobular carcinomas, and this is observed at both in situ and invasive cases.
然而，该导管内癌不仅限于导管，还向外浸润至周围间质而成了浸润性导管癌。
However, this ductal carcinoma is not confined to just the duct, but infiltrates outward into the surrounding stroma as an infiltrating ductal carcinoma.
在这个试验中，入选标准为年龄大于45岁经历保乳手术的浸润性导管癌的患者。
In this trial, women aged at least 45 years with invasive ductal breast carcinoma undergoing breast-conserving surgery were enrolled.
免疫组化研究对于判断涎腺导管癌早期局部复发、远处转移和生存率有所帮助。
Immunohistochemical study was linked to the early local disease recurrence, distant disease metastasis and survival rates.
不同组织学类型TAM抑制率实验似有差异，髓样癌的阳性检出率较浸润性导管癌高。
The TAM positive rate in medullary cancer was higher than that in other pathologic types of breast tumors and it was the lowest in ductal cancers.
结论鳞样小汗腺导管癌是一种非常罕见的低度恶性肿瘤，局部切除后可复发，未见转移报道。
Conclusions Squamoid eccrine ductal carcinoma is an exceedingly rare low-grade malignant tumor and can recur after excision but do not metastasize.
导管内癌（或伴早浸）与浸润性导管癌相比，表达水平低，差异有显著性意义（P<0.05）。
There was also significant difference between ductal carcinoma in situ (or with early infiltration) and invasive ductal carcinoma (P<0.05), and the former was weaker.
因为这种肿瘤非正常生长通常并不显示出长期的风险，一些专家质疑原位导管癌(DCIS)是否需要治疗。
Some experts question the need to treat DCIS at all, since the abnormal growths usually pose no long-term risks.
在胰导管癌切除术后，541名患者被随机分为4个治疗组：化放疗组、化疗组、化放疗与化疗联合应用组和单纯观察组。
After resection of pancreatic ductal carcinoma, 541 patients were randomized to one of four treatment groups: chemoradiotherapy, chemotherapy, both treatments, or observation only.
与肝癌密切关联的是肝内胆道癌，发生于由肝脏向小肠输送胆汁的导管内。
A closely related cancer is intrahepatic bile duct cancer, which occurs in the duct that carries bile from the liver to the small intestine.
结论胰腺腺泡细胞癌属于高度恶性肿瘤，在细胞学形态和免疫表型方面均与胰腺导管细胞肿瘤以及胰腺内分泌肿瘤不同。
Conclusions Acinar cell carcinoma is a high-grade tumor and different from pancreatic ductal carcinoma and endocrine tumors in the morphology and immunophenotype.
导管内癌高倍放大图。
This high power microscopic view demonstrates intraductal carcinoma.
食管癌切除，术中作预防性胸导管结扎，可减少乳糜胸的发生率。
Preventive surgical ligation of thoracic duct during the course of esophageal carcinoma resection can reduce the incidence of postoperative chylothorax.
目的：评价晚期贲门癌经导管血管内灌注化疗的临床应用价值。
Objective: To evaluate the clinical value of transcatheter endovascular perfusion chemotherapy in advanced cardial carcinoma.
膈上水平胸导管结扎对治疗和预防食管癌术后乳糜胸疗效确切。
The efficacy of ligation of the thoracic duct above the diaphrenic level for treatment prevention of postoperative chylothorax is definitive and accurate.
导管原位癌(DCIS)的高发病率和治疗多样化促使人们探究各种治疗的比较效应。
Background the high incidence of ductal carcinoma in situ (DCIS) and variations in its treatment motivate inquiry into the comparative effectiveness of treatment options.
值得注意的是中心处筛型且有明显微钙化的导管内癌组成部分。
Note the intraductal component in the center with cribriform pattern and prominent microcalcifications.
方法：对9例癌性腹水患者给予中心静脉导管作持续腹腔引流及行腹腔内灌注化疗。
Methods: the continuous intraperitoneal drainage by central venous catheter and intraperitoneal perfusion of chemotherapeutic drugs were applied to 9 patients with carcinomatous ascites.
方法：对9例癌性腹水患者给予中心静脉导管作持续腹腔引流及行腹腔内灌注化疗。
Methods: the continuous intraperitoneal drainage by central venous catheter and intraperitoneal perfusion of chemotherapeutic drugs were applied to 9 patients with carcinomatous ascites.
应用推荐